The gene RNF114 (ring finger protein 114) is mapped to human chromosome 20q13.13. The expression of RNF114 increases at the late G1 phase. The protein localizes in the cytoplasm and nucleus. RNF114 is also referred to as ZNF313 (zinc finger protein 313).
Synonyms: Anti-RING finger protein 114; Anti-Zinc finger protein 313
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: RNF114 (ring finger protein 114) is an ubiquitin E3 ligase. It is needed for regulation of cell cycle progression, differentiation and senescence. It is responsible for degradation of p21 and destabilization of p27 and p57. In addition, RNF114 might be associated with pathogenesis of multiple human cancers. Mutations in RNF114 are linked with psoriasis, an immune-induced skin disorder.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC